{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:25:41Z","timestamp":1786119941904,"version":"build-2736575974"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["24K02193"],"award-info":[{"award-number":["24K02193"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>\n                      <jats:italic toggle=\"yes\">Scedosporium<\/jats:italic>\n                      spp. typically infect the lungs and can disseminate to various tissues, including the central nervous system (CNS). Voriconazole and terbinafine are both used to treat scedosporiosis. While voriconazole has been reported to have good CNS permeability, the permeability of terbinafine in humans remains unclear.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      The authors describe a case of\n                      <jats:italic toggle=\"yes\">Scedosporium apiospermum<\/jats:italic>\n                      infection with brain abscesses in a lung transplant recipient treated with voriconazole and terbinafine. Drug concentrations were measured in the biopsied brain abscess, the surrounding normal cerebrum, serum, and cerebrospinal fluid (CSF). Brain-to-serum and CSF-to-serum partition coefficients for each drug were calculated based on serum concentrations estimated at the time of abscess biopsy and lumbar puncture using population pharmacokinetic models.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Trough serum concentrations of voriconazole and terbinafine were 6.28 mcg\/mL and 0.41 mcg\/mL, respectively. Seven hours after administration, the concentrations in cerebrum were 5.65 mcg\/mL and 0.85 mcg\/mL, respectively, and those in brain abscess were 4.05 mcg\/mL and 1.06 mcg\/mL, respectively. The estimated brain-to-serum partition coefficients were 0.730 for voriconazole and 0.553 for terbinafine, indicating substantial penetration of both drugs into the infected tissue. The brain abscess size decreased in this case, suggesting a therapeutic antifungal effect of these agents. However, the measured CSF concentrations at 5 hours postdose were 2.69 mcg\/mL for voriconazole and &lt;0.002 mcg\/mL for terbinafine. The CSF-to-serum partition coefficients were 0.365 for voriconazole and &lt;5.64 \u00d7 10\n                      <jats:sup>\u22124<\/jats:sup>\n                      for terbinafine, indicating poor CSF permeability of terbinafine.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>These findings suggest that terbinafine has the potential to treat fungal infections within the brain, but may be less effective for CSF infections. Further studies are warranted to clarify incorporation of these agents into CNS infection treatment strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ftd.0000000000001362","type":"journal-article","created":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T18:00:42Z","timestamp":1753120842000},"page":"134-139","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Efficient Penetration of Terbinafine into Brain Abscesses in a Lung Transplant Recipient with Scedosporiosis: A Short Communication"],"prefix":"10.1097","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1963-2510","authenticated-orcid":false,"given":"Keisuke","family":"Umemura","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Sakyo-ku, Kyoto, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yurie","family":"Katsube","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Sakyo-ku, Kyoto, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Tsuchido","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory Medicine, Graduate School of Medicine, Kyoto University, Sakyo-ku, Kyoto, Japan;"},{"name":"Department of Infection Control and Prevention, Kyoto University Hospital, Sakyo-ku, Kyoto, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Katada","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Sakyo-ku, Kyoto, Japan;"},{"name":"Department of Infection Control and Prevention, Kyoto University Hospital, Sakyo-ku, Kyoto, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiki","family":"Hira","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Sakyo-ku, Kyoto, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayoshi","family":"Kawata","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Sakyo-ku, Kyoto, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamiko","family":"Saigo","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Sakyo-ku, Kyoto, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Tsuda","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Sakyo-ku, Kyoto, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsaku","family":"Nakagawa","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Sakyo-ku, Kyoto, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etsuko Yamamoto","family":"Hattori","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Graduate School of Medicine, Kyoto University, Sakyo-ku, Kyoto, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megumi","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Graduate School of Medicine, Kyoto University, Sakyo-ku, Kyoto, Japan; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Sakanoue","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Graduate School of Medicine, Kyoto University, Sakyo-ku, Kyoto, Japan; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Ohsumi","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Graduate School of Medicine, Kyoto University, Sakyo-ku, Kyoto, Japan; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Mizuno","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Arakawa","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Graduate School of Medicine, Kyoto University, Sakyo-ku, Kyoto, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Date","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Graduate School of Medicine, Kyoto University, Sakyo-ku, Kyoto, Japan; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miki","family":"Nagao","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory Medicine, Graduate School of Medicine, Kyoto University, Sakyo-ku, Kyoto, Japan;"},{"name":"Department of Infection Control and Prevention, Kyoto University Hospital, Sakyo-ku, Kyoto, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Terada","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Sakyo-ku, Kyoto, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,7,21]]},"reference":[{"key":"R1-20260108","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.resinv.2013.07.001","article-title":"Scedosporium aurantiacum brain abscess after near-drowning in a survivor of a tsunami in Japan","volume":"51","author":"Nakamura","year":"2013","journal-title":"Respir Investig."},{"key":"R2-20260108","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.mmcr.2017.06.001","article-title":"Scedosporium apiospermum brain abscesses in a patient after near-drowning\u2014a case report with 10-year follow-up and a review of the literature","volume":"17","author":"Signore","year":"2017","journal-title":"Med Mycol Case Rep."},{"key":"R3-20260108","doi-asserted-by":"crossref","first-page":"e246","DOI":"10.1016\/S1473-3099(20)30784-2","article-title":"Global guideline for the diagnosis and management of rare mould infections: an initiative of the European confederation of medical mycology in cooperation with the international society for human and animal mycology and the American society for microbiology","volume":"21","author":"Hoenigl","year":"2021","journal-title":"Lancet Infect Dis."},{"key":"R4-20260108","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1080\/13693780802510224","article-title":"Antifungal Activity against Scedosporium species and novel assays to assess antifungal pharmacodynamics against filamentous fungi","volume":"47","author":"Wiederhold","year":"2009","journal-title":"Med Mycol."},{"key":"R5-20260108","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1111\/myc.13157","article-title":"Antifungal drugs: an updated review of central nervous system pharmacokinetics","volume":"63","author":"Wirth","year":"2020","journal-title":"Mycoses"},{"issue":"suppl 1","key":"R6-20260108","doi-asserted-by":"crossref","first-page":"S387","DOI":"10.1080\/13693780802537953","article-title":"Cerebral aspergillosis: tissue penetration is the key","volume":"47","author":"Schwartz","year":"2009","journal-title":"Med Mycol."},{"key":"R7-20260108","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1128\/AAC.44.11.3087-3091.2000","article-title":"Comparative efficacies of terbinafine and fluconazole in treatment of experimental coccidioidal meningitis in a rabbit model","volume":"44","author":"Sorensen","year":"2000","journal-title":"Antimicrob Agents Chemother."},{"key":"R8-20260108","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1002\/jps.1132","article-title":"Tissue distribution of terbinafine in rats","volume":"90","author":"Hosseini-Yeganeh","year":"2001","journal-title":"J Pharm Sci."},{"key":"R9-20260108","doi-asserted-by":"crossref","first-page":"e4543","DOI":"10.1002\/bmc.4543","article-title":"Determination of terbinafine in human plasma using UPLC-MS\/MS: application to a bioequivalence study in healthy subjects","volume":"33","author":"Bhadoriya","year":"2019","journal-title":"Biomed Chromatogr."},{"key":"R10-20260108","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10928-015-9462-9","article-title":"Determination of a suitable voriconazole pharmacokinetic model for personalised dosing","volume":"43","author":"McDougall","year":"2016","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"R11-20260108","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1248\/bpb.b16-01004","article-title":"Analysis of the mechanism of prolonged persistence of drug interaction between terbinafine and amitriptyline or nortriptyline","volume":"40","author":"Mikami","year":"2017","journal-title":"Biol Pharm Bull."},{"key":"R12-20260108","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1128\/AAC.46.7.2219-2228.2002","article-title":"Physiologically based pharmacokinetic model for terbinafine in rats and humans","volume":"46","author":"Hosseini-Yeganeh","year":"2002","journal-title":"Antimicrob Agents Chemother."},{"key":"R13-20260108","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1086\/377131","article-title":"Voriconazole concentrations in the cerebrospinal fluid and brain tissue of Guinea pigs and immunocompromised patients","volume":"37","author":"Lutsar","year":"2003","journal-title":"Clin Infect Dis."},{"issue":"suppl 1","key":"R14-20260108","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cmi.2018.01.002","article-title":"Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS Guideline","volume":"24","author":"Ullmann","year":"2018","journal-title":"Clin Microbiol Infect."},{"key":"R15-20260108","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/00365540600786564","article-title":"Scedosporium Prolificans brain abscess in a patient with chronic granulomatous disease: successful combination therapy with voriconazole and terbinafine","volume":"39","author":"Bhat","year":"2007","journal-title":"Scand J Infect Dis."},{"key":"R16-20260108","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2174\/1389200043489126","article-title":"Drug transport at the blood-brain barrier and the choroid plexus","volume":"5","author":"Graff","year":"2004","journal-title":"Curr Drug Metab."},{"key":"R17-20260108","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1128\/AAC.47.1.106-117.2003","article-title":"In Vitro drug interaction modeling of combinations of azoles with terbinafine against clinical Scedosporium prolificans isolates","volume":"47","author":"Meletiadis","year":"2003","journal-title":"Antimicrob Agents Chemother."}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/FTD.0000000000001362","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T19:31:29Z","timestamp":1786044689000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/FTD.0000000000001362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,21]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000001362","relation":{},"ISSN":["0163-4356","1536-3694"],"issn-type":[{"value":"0163-4356","type":"print"},{"value":"1536-3694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,21]]},"assertion":[{"value":"2025-01-23","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-05","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}